Dr. Stolarski is a Board Certified Orthopedic Surgeon with advanced training and interest in minimally invasive hip and knee replacements as well as complex revisions. Dr. Stolarski completed his ACGME-accredited Adult Reconstruction Fellowship at the University of Pennsylvania under the mentorship of Drs. Paul Lotke, Jonathan Garino, and Charles Nelson. He previously practiced at the Cleveland Clinic where he played a large role in the development of their joint program. Dr. Stolarski is an industry leader and developer of new approaches to joint replacement allowing quicker rehabilitation and shorter hospital stays. His interest in research and the advancement of the treatment of arthritis keeps him abreast of new developments such as computer/image-guided joint replacement systems. He has published articles and textbook chapters in orthopedic literature. Dr. Stolarski also welcomes those that have had their joints replaced and are now having problems. He enjoys the complexity and challenges of problematic joint replacements.
Edward Stolarski, M.D., P.A.
-
EDUCATION
June 1993 – May 1997 MD Hahnemann University
School of MedicineSeptember 1997 – May 1997 BS Electrical Engineering
Drexel University -
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS
August 2002 – July 2003 Adult Reconstruction Fellowship
AGGME Accredited
University of Pennsylvania
Drs. Paul Lotke, Jonathon Garino, Charles NelsonJuly 1997 – July 2002 Resident, Orthopedic Surgery
Temple University, Philadelphia, PA -
RESEARCH
February 2006 Modern Minimally Invasive Total Hip Arthroplasty Through An Anterior Supine Surgical ApproachWhite Paper, Co-AuthorJanuary 2006 Anterior Supine IntermuscularMinimally Invasive Hip Operative TechniqueCo-AuthorNovember 2004 “Review of thromboembolic disease after total jointarthroplasty”Article in progressMay 2000 “Pullout strength comparison between two types of fixationfor biceps to triceps transfer”, Stolarski, E.Research Day, Shriner’s Hospital, Philadelphia, PAJune 1999 “The effect of fibular osteotomy on tibial medial openingwedge osteotomy”, Massina, M., Stolarski, E.,Poster Presentation, Orlando, FL -
LICENSURE
Pennsylvania
Florida -
PROFESSIONAL EXPERIENCE
September 2006 – Present Orthopedic Surgeon
Sub Specialty: Adult Reconstruction
Kennedy White Orthopedic Center
Sarasota, FloridaAugust 2003 – August 2006 Orthopedic Surgeon
Sub Specialty: Adult Reconstruction
Cleveland Clinic Hospital
Naples, Florida -
PROFESSIONAL EXPERIENCE / NON-ORTHOPEDIC
June 1992 – May 1994 Computer Systems Engineer
Comptek Federal Systems, Mount Laurel, NJJune 1989 – December 1989 Assistant Engineer (Co-Op)
General Electric, Mount Laurel, NJ
Weapons and Radar DivisionJune 1998 – December 1988 Assistant Engineer (Co-Op)
Philadelphia Gas Works
Philadelphia, PA
Control and Distribution -
PROFESSIONAL MEMBERSHIPS
AOA Honor Society
American Academy of Orthopedic Surgeons -
SPECIALTY COURSES
April 2006 Faculty for Anterior Supine THA
AAOS/AAHKS Impact of Evolving Technology
on Hip & KneeArthritis and Reconstruction
Ponte Vedra Beach, FLMarch 2005 Anterior Supine Approach to Total Hip
Aalst, BelgiumDecember 2004 Anterolateral Approach to Total Hip
Celebration, FLAugust 2004 Quadriceps Sparing Total Knee Training
Warsaw, IN
July 2004 Oxford UKA Training
Dallas, TXJune 2004 2-Incision Training for Total Hip Arthroplasty
Dallas, TXMay 2004 Current Concepts in Joint Replacement
Las Vegas, NVNovember 2002 Total Hip and Knee Symposium
Los Cabos, MexicoOctober 2001 Strategies to Improve Outcomes in Joint Replacement,
Palm Springs, CAMay 2001 Advanced Cardiac Life Support, Philadelphia, PA
September 1999 AO Basic Fracture Management Course, Chicago, ILJuly 1998 Advanced Trauma Life Support, Philadelphia, PA
-
BIOMET FACULTY – TRAINING EVENTS
December 2, 2011 Henderson, NV – Arcos Modular Femoral Revision System
Instructional CourseDecember 1, 2011 Henderson, NV – Anterior Supine Intermuscular (ASI)
Instructional CourseApril 11, 2011 Jupiter, FL – Arcos Modular Femoral Revision System
TalkApril 8, 2011 Henderson, NV – Arcos Modular Femoral Revision System
Instructional CourseApril 7, 2011 Henderson, NV – Anterior Supine Intermuscular (ASI)
Instructional CourseOctober 9, 2010 Baltimore, MD – Arcos Modular Femoral Revision System
Instructional CourseOctober 8, 2010 Baltimore, MD – Microplasty ASI Instructional Course
February 5, 2010 Miami, FL – Microplasty ASI Instructional Course
November 20, 2009 Microplasty ASI Masters Course
May 8, 2009 Microplasty ASI Instructional Course
February 13, 2009 Micoplasty ASI Instructional Course
-
Visiting Surgeons (ASI)
March 7, 2011 Dr. Robert Little Orthopaedic Associates of Rochester, P.C.
Rochester, NYDecember 16, 2010 Dr. William Pujadas Jacksonville Orthopaedic Institute
Jacksonville, FLDecember 7, 2010 Dr. Charles Mess Potomac Valley Orthopedics, Olney, MD
April 14, 2010 Dr. David Heligman Institute for Orthopaedic Surgery
& Sports, Fort Myers, FL -
CLINICAL RESEARCH
Sub-Investigator
Astellas A randomized, double-blind, double-dummy, parallel group study to compare XXXXX bid and qd doses and enoxaparin for prevention of venous thromboembolism in subjects undergoing elective hip replacement surgery: A phase IIb study to evaluate the efficacy and safety of XXXXX compared to enoxaparin in subjects undergoing elective hip replacement surgery
Eli Lilly A Phase 2 randomized study to investigate the efficacy and safety of XXXXX versus placebo in older patients undergoing elective total hip arthroplasty (eTHA)
Novum A Phase 3, double-blind, randomized, lacebo-controlled, parallel group, multi-site study to evaluate the clinical equivalence of XXXXX with Voltaren® Gel (diclofenac sodium topical gel) 1% in patients with osteoarthritis of the knee
Pfizer A phase 3, multi-center, randomized, double-blind, controlled study of the long term analgesic efficacy and safety of XXXXX alone or in combination with non-steroidal anti-inflammatory drugs (NSAIDS) versus NSAIDS along in patients with osteoarthritis of the knee or hip
Pfizer A phase 3 randomized, double-blind, placebo-controlled multicenter study of XXXXX on peripheral nerve function in patients with osteoarthritis
Pfizer A phase 3, double blind, placebo-controlled, multicenter, long-term safety study of XXXXX in patients with osteoarthritis of the knee of hip
Pfizer A phase 3 randomized, double-blind, placebo- and oxycodone-controlled, multicenter study of the efficacy and safety of XXXXX in patients with osteoarthritis of the knee or hip
Purdue Pharma A Phase 3 randomized, double-blind, placebo-controlled, multicenter trial with an enriched study design to assess the efficacy and safety of XXXXX compared to placebo in opioid-experience subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy
QRx Pharma A phase 3 randomized, double-blind study of the analgesic efficacy and safety of flexible dose XXXXX versus low dose XXXXX in patients who have undergone primary unilateral total knee arthroplasty
Stryker A phase 2 double-blind, randomized, placebo-controlled, proof of concept, dose finding study of intraarticular XXXXX in subjects with osteoarthritis (OA) of the knee
Stryker A phase 2 open label, safety extension study of repeat dosing with intraarticular XXXX in subjects with osteoarthritis (OA) of the knee